XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.bigmoleculewatch.com/2017/02/28/genentech-v-amgen-amgen-seeks-dismissal-under-amgen-v-sandoz/20%Monthly2018-05-25 18:10
https://www.bigmoleculewatch.com/2017/02/28/janssen-v-celltrion-celltrion-moves-to-dismiss-for-lack-of-standing/20%Monthly2018-07-25 16:07
https://www.bigmoleculewatch.com/2017/02/27/ptab-institutes-review-of-biogens-rituximab-patent/20%Monthly2018-01-10 18:53
https://www.bigmoleculewatch.com/2017/02/27/pharmaceutical-care-management-association-national-association-of-chain-drug-stores-and-healthcare-supply-chain-association-file-amicus-brief-in-sandoz-v-amgen/20%Monthly2018-06-04 14:36
https://www.bigmoleculewatch.com/2017/02/24/mylan-apotex-coherus-and-adello-file-amicus-briefs-in-sandoz-v-amgen/20%Monthly2018-06-04 14:37
https://www.bigmoleculewatch.com/2017/02/23/aarp-ahip-and-others-file-amicus-briefs-in-sandoz-v-amgen/20%Monthly2018-06-04 14:38
https://www.bigmoleculewatch.com/2017/02/23/genentech-requests-expedited-resolution-of-patent-dance-dispute-against-amgen/20%Monthly2018-07-25 16:08
https://www.bigmoleculewatch.com/2017/02/23/biosimilars-council-files-amicus-brief-in-sandoz-v-amgen/20%Monthly2018-06-04 14:44
https://www.bigmoleculewatch.com/2017/02/22/ptab-denies-institution-of-ipr-on-genentechs-protein-folding-patent/20%Monthly2018-01-10 19:24
https://www.bigmoleculewatch.com/2017/02/22/celltrion-files-petition-for-ipr-of-genentechs-trastuzumab-patent/20%Monthly2018-01-10 19:26
https://www.bigmoleculewatch.com/2017/02/22/celltrion-healthcare-and-pfizer-present-data-on-infliximab-trial/20%Monthly2018-01-10 19:25
https://www.bigmoleculewatch.com/2017/02/22/united-states-amicus-brief-filed-in-sandoz-v-amgen/20%Monthly2018-06-04 14:45
https://www.bigmoleculewatch.com/2017/02/21/upcoming-oral-arguments-in-bpcia-litigation/20%Monthly2018-05-25 17:54
https://www.bigmoleculewatch.com/2017/02/17/ptab-grants-apotexs-petition-for-ipr-on-amgens-neulasta-pegfilgrastim-patent/20%Monthly2018-05-25 17:52
https://www.bigmoleculewatch.com/2017/02/17/bpcia-litigation-roundup-midwinter-2017/20%Monthly2018-05-25 17:51
https://www.bigmoleculewatch.com/2017/02/17/janssen-v-celltrion-trial-postponed-briefing-and-hearings-scheduled-on-standing-damages-issues/20%Monthly2018-05-25 17:48
https://www.bigmoleculewatch.com/2017/02/16/genentech-files-dj-action-against-amgen-regarding-avastin-biosimilar/20%Monthly2018-07-25 16:09
https://www.bigmoleculewatch.com/2017/02/16/fda-accepts-mylan-abla-for-pegfilgrastim-biosimilar/20%Monthly2018-01-10 19:39
https://www.bigmoleculewatch.com/2017/02/15/summary-of-sandozs-opening-brief-in-sandoz-v-amgen/20%Monthly2018-06-04 14:47
https://www.bigmoleculewatch.com/2017/02/14/briefing-complete-in-appeal-in-amgen-v-apotex/20%Monthly2018-07-25 16:09
https://www.bigmoleculewatch.com/2017/02/13/pfizer-to-close-australian-plant/20%Monthly2018-01-10 19:44
https://www.bigmoleculewatch.com/2017/02/13/sandoz-files-opening-brief-to-supreme-court-in-sandoz-v-amgen/20%Monthly2018-06-04 14:48
https://www.bigmoleculewatch.com/2017/02/11/praluent-injunction-stay/20%Monthly2018-01-10 19:46
https://www.bigmoleculewatch.com/2017/02/09/aurobindo-pharma-acquires-four-biosimilar-products-from-tl-pharmaceutical/20%Monthly2018-01-10 19:47
https://www.bigmoleculewatch.com/2017/02/09/market-watch-arven-pharmaceuticals-bulks-up-with-ge-healthcares-flexfactory/20%Monthly2018-01-10 19:47
https://www.bigmoleculewatch.com/2017/02/09/deal-watch-coherus-announces-public-common-stock-offering/20%Monthly2018-01-10 19:48
https://www.bigmoleculewatch.com/2017/02/08/merck-v-gnosis-ipr-standard/20%Monthly2017-02-16 20:49
https://www.bigmoleculewatch.com/2017/02/07/framework-agreement-update/20%Monthly2018-01-10 19:52
https://www.bigmoleculewatch.com/2017/02/06/zioxtenzo-withdrawal-european-application/20%Monthly2018-01-10 19:54
https://www.bigmoleculewatch.com/2017/02/03/amgen-reports-on-neulasta-neupogen-biosimilar-competition-and-acceptance-of-avastin-biosimilar-abla/20%Monthly2018-01-10 19:58
https://www.bigmoleculewatch.com/2017/02/02/biosimilar-updates-epoetin-rituximab-adalimumab/20%Monthly2018-01-10 21:13